NDC Package 82393-118-02 Fentanyl Citrate

Powder - View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

82393-118-02

Package Description:

.1 g in 1 VIAL, GLASS

Product Code:

82393-118

Non-Proprietary Name:

Fentanyl Citrate

Substance Name:

Fentanyl Citrate

Usage Information:

This medication is used to help relieve sudden (breakthrough) pain in people who are already taking opioid medication around-the-clock for cancer pain. Fentanyl belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. This medication should not be used to relieve mild or short-term pain (such as due to headache/migraine, dental procedures, surgery).

11-Digit NDC Billing Format:

82393011802

Product Type:

Bulk Ingredient

Labeler Name:

Pharma Source Direct, Inc.

Dosage Form:

Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.

Active Ingredient(s):

FENTANYL CITRATE 1 g/g

DEA Schedule:

Schedule II (CII) Substances

Sample Package:

N/A

Marketing Category:

BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.

Start Marketing Date:

01-15-2022

Listing Expiration Date:

12-31-2024

Exclude Flag:

Unfinished Product:

Yes

Code Structure:

82393 - Pharma Source Direct, Inc.
- 82393-118 -
  - 82393-118-02 - .1 g in 1 VIAL, GLASS

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
82393-118-03	.5 g in 1 VIAL, GLASS
82393-118-04	1 g in 1 VIAL, GLASS
82393-118-05	5 g in 1 BOTTLE, GLASS
82393-118-07	25 g in 1 BOTTLE, GLASS
82393-118-08	100 g in 1 BOTTLE, GLASS

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 82393-118-02?

The NDC Packaged Code 82393-118-02 is assigned to an UNFINISHED drug package of .1 g in 1 vial, glass of Fentanyl Citrate, a bulk ingredient labeled by Pharma Source Direct, Inc.. The product's dosage form is powder and is administered via form.

Is NDC 82393-118 included in the NDC Directory?

Yes, Fentanyl Citrate is an UNFINISHED PRODUCT with code 82393-118 that is active and included in the NDC Directory. The product was first marketed by Pharma Source Direct, Inc. on January 15, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 82393-118-02?

The 11-digit format is 82393011802. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	82393-118-02	5-4-2	82393-0118-02

Table of Contents